Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era
- 31 October 2003
- journal article
- Published by Elsevier BV in Surgery
- Vol. 134 (4), 656-665
- https://doi.org/10.1016/s0039-6060(03)00314-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Management of malignant gastrointestinal stromal tumoursThe Lancet Oncology, 2002
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Diagnosis of gastrointestinal stromal tumors: A consensus approachHuman Pathology, 2002
- Clinical management of gastrointestinal stromal tumors: Before and after STI-571Human Pathology, 2002
- Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I studyThe Lancet, 2001
- The Effect of Surgery and Grade on Outcome of Gastrointestinal Stromal TumorsArchives of Surgery, 2001
- Malignant Gastrointestinal Stromal Tumors of the Small Intestine: A Review of 50 Cases From a Prospective DatabaseAnnals of Surgical Oncology, 2001
- Two Hundred Gastrointestinal Stromal TumorsAnnals of Surgery, 2000
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Neuroectodermal Differentiation of the Gastrointestinal Tumors in the Carney TriadThe American Journal of Surgical Pathology, 1993